References
- Abdolmaleki Z., Mashak Z., Dehkordi F.S.: Phenotypic and genotypic characterization of antibiotic resistance in the methicillin resistant Staphylococcus aureus strains isolated from hospital cockroaches. Antimicrob. Resist. In. DOI: 10.1186/s13756-019-0505-7 (2019)
- Agarwal R., Bartsch S.M., Kelly B.J., Prewitt M., LiuY., Chen Y., Umscheid C.A.: Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis. Clin. Microbiol. Infec. 24, 361–368 (2018)
- Alen S. van, Ballhausen B., Peters G., Friedrich A.W.,Mellmann A., Köck R., Becker K.: In the centre of an epidemic: Fifteen years of LA-MRSA CC398 at the University Hospital Münster. Vet. Microbiol. DOI: 10.1016/j.vetmic.2016.01.021 (2016)
- Algammal A., Hetta H.F., Elkelish A., Alkhalifah D., Hozzein W., Batiha G., El Nahhas N., Mabrok M.: Methicillin-Resistant Staphylococcus aureus (MRSA): One Health Perspective Approach to the Bacterium Epidemiology, Virulence Factors, Antibiotic-Resistance, and Zoonotic Impact. Infection and Drug Resistance, 13, 3255–3265 (2020)
- Alkharsah K.R., Rehman S., Alkhamis F., Alnimr A., Diab A., Al Ali A.K.: Comparative and molecular analysis of MRSA isolates from infection sites and carrier colonization sites. Ann. Clin. Microb. Anti. DOI:10.1186/s12941-018-0260-2 (2018)
- Alkharsah K.R., Rehman S., Alnimr A., Diab A., Hawwari A., Tokajian S.: Molecular typing of MRSA isolates by spa and PFGE. Journal of King Saud University – Science, 31, 999–1004 (2019)
- Andrade-Figueiredo M., Leal-Balbino T.C.: Clonal diversity and epidemiological characteristics of Staphylococcus aureus: high prevalence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with clinical isolates in Brazil. BMC Microbiol. DOI 10.1186/s12866-016-0733-4 (2016)
- Auer G.K., Weibel D.B.: Bacterial cell mechanics. Biochemistry, 56, 3710–3724 (2017)
- Bal A.M., Coombs G., Holden M.T.G., Lindsay J.A., Nimmo G.R., Tattevin P., Skov R.L.: Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: Blurring of the traditional definitions. J. Glob. Antimicrob. Re. 6, 95–101 (2016)
- Becker K., van Alen S., Idelevich E.A., Schleimer N., Seggewiß J., Mellmann A., Kaspar U., Peters G.: Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus. Emerg. Infect. Dis. 24, 242–248 (2018)
- Bitrus A.A., Peter O.M, Abbas M.A, Goni M.D.: Staphylococcus aureus: A Review of Antimicrobial Resistance Mechanisms. Veterinary Sciences: Research and Reviews, 4, 43–54 (2018)
- Ciesielczuk H., Xenophontos M., Lambournea J.: Methicillin-Resistant Staphylococcus aureus Harboring mecC Still Eludes Us in East London, United Kingdom. J. Clin. Microbiol. 57, e00020–19 (2019)
- Dadashi M., Nasiri M.J., Fallah F., Owlia P., Hajikhani B., Emaneini M.: Methicillin-resistant Staphylococcus aureus (MRSA) in Iran: A systematic review and meta-analysis. J. Glob. Antimicrob. Re. 12, 96–103 (2018)
- Dadej R., Jędrzejczak-Dadej A.: Zakażenia układu moczowego u mężczyzn w podeszłym wieku. Geriatria, 3, 151–161 (2009)
- Deepashree R., Khanum S., Sujatha S., Tejashree A., Prasad N., Rayma B.: Methicillin-resistant Staphylococcus aureus (MRSA) carriage among health care personnel in non outbreak settings in tertiary care hospital in Mysore, Am. J. Infect. Control. 49, 1499–1502 (2021)
- Depardieu F., Podglajen I., Leclercq R., Collaz E., Courvalin P.: Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20, 79–114 (2007)
- Eliakim-Raz N., Hellerman M., Yahav D., Cohen J., Margalit I., Fisher S., Zusman O., Shaked H., Bishara J.: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study. J. Antimicrob. Chemoth. 72, 882–887 (2017)
- El-Jakee J., Nagwa A.S., Bakry M., Zouelfakar S., Elgabry E., Gad El-Said W.A.: Characteristics of Staphylococcus aureus strains isolated from human and animal sources. American-Eurasian J. Agric. & Environ. Sci. 4, 221–229 (2008)
- Ernst C.M, Peschel A.: MprF-mediated daptomycin resistance. Int. J. Med. Microbiol. 309, 359–363 (2019)
- Figueiredo A.M.S.: What is behind the epidemiological difference between community-acquired and health-care associated methicillin-resistant Staphylococcus aureus? Virulence, 8, 640–642 (2017)
- Foster T.J.: Antibiotic resistance in Staphylococcus aureus. Status and prospects. FEMS Microbiol. Rev. 41, 430–449 (2017)
- Foster T.J.: Can β-Lactam Antibiotics Be Resurrected to Combat MRSA? Trends Microbiol. 27, 26–38 (2019)
- Fowler Jr V.G., Cosgrove S.E. i wsp.: Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus. New Engl. J. Med. 355, 653–665 (2006)
- García-de-la-Mària C., Miró J.M. i wsp.: The combination of daptomycin and fosfomycin has synergistic, potent, and rapid bactericidal activity against methicillin-resistant Staphylococcus aureus in a rabbit model of experimental endocarditis. Antimicro. Agents. Chemother. DOI: 10.1128/AAC.02633-17 (2018)
- Garoy E.Y., Gebreab Y.B., Achila O.O., Tekeste D.G., Kesete R., Ghirmay R., Kiflay R., Tesfu T.: Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Patients – A Multicenter Study in Asmara, Eritrea. Can. J. Infect. Dis. Med. DOI:10.1155/2019/8321834 (2019)
- Giulieri S.G., Tong S.Y.C., Williamson D.A.: Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureus infections. Microbial Genomics, DOI: 10.1099/mgen.0.000324 (2020)
- Gnanamani A, Hariharan P, Paul-Satyaseela M.: Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach. Frontiers in Staphylococcus aureus, DOI: 10.5772/67338 (2017)
- Gostev V., Kruglov A., Kalinogorskaya O., Dmitrenko O., Khokhlova O., Yamamoto T., Lobzin Y., Ryabchenko I., Sidorenko S.: Molecular epidemiology and antibiotic resistance of methicillin-resistant Staphylococcus aureus circulating in the Russian Federation. Infect. Genet. Evol. 53, 189–194 (2017)
- Guthridge I., Smith S., Law M., Binotto E., Hanson J.: Efficacy and Safety of Intravenous Lincosamide Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob. Agents Ch. DOI: 10.1128/AAC.00343-21 (2021)
- Hamzah A.M.C., Yeo C.C., Puah S.M., Chua K.H., Chew CH.: Staphylococcus aureus Infections in Malaysia: A Review of Antimicrobial Resistance and Characteristics of the Clinical Isolates, 1990–2017. Antibiotics, DOI:10.3390/antibiotics8030128 (2019)
- Harkins C.P., Pichon B., Doumith M., Parkhill J., Westh H., Tomasz A., de Lencastre H., Bentley S.D., Kearns A.M., Holden M.T.G.: Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol. DOI: 10.1186/s13059-017-1252-9 (2017)
- Harris L.G., Foster S.J., Richards R.G.: An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. European cells and Materials, 4, 39–60 (2002)
- Hassoun A., Linden P.K., Friedman B.: Incidence, prevalence, and management of MRSA bacteremia across patient populations – a review of recent developments in MRSA management and treatment. Crit. Care. DOI 10.1186/s13054-017-1801-3 (2017)
- Hatcher S.M., Heaney C. i wsp.: The Prevalence of Antibiotic-Resistant Staphylococcus aureus Nasal Carriage among Industrial Hog Operation Workers, Community Residents, and Children Living in Their Households: North Carolina, USA. Environ. Health Persp. 125, 560–569 (2016)
- Heidary M., Khosravi A.D., Khoshnood S., Nasiri M.J., Soleimani S., Goudarzi M.: Daptomycin. J. Antimicrob. Chemother. 73, 1–11 (2018)
- Hepburn L., Hijnen D.J., Sellman B.R., Mustelin T., Sleeman M.A., May R.D., Strickland I.: The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies. Brit. J. Dermatol. 177, 63–71 (2016)
- Hetem D.J., Derde L.P.G., Empel J., Mroczkowska A., Orczykowska-Kotyna M., Kozińska A., Hryniewicz W., Goossens H., Bonten M.J.M. on behalf of the MOSAR WP3 Study Group.: Molecular epidemiology of MRSA in 13 ICUs from eight European countries. J. Antimicrob. Chemoth. 71, 45–52 (2016)
- Holland T.L., Arnold C., Fowler Jr V.G.: Clinical management of Staphylococcus aureus bacteremia: a review. JAMA, 312, 330–341 (2014)
- Hombach M., Pfyffer G.E., Roos M., Lucke K.: Detection of Methicillin-Resistant Staphylococcus aureus (MRSA) in Specimens from Various Body Sites: Performance Characteristics of the BD Gene Ohm MRSA Assay, the Xpert MRSA Assay, and Broth-Enriched Culture in an Area with a Low Prevalence of MRSA Infections. J. Clin. Microbiol. 48, 3882–3887 (2010)
- Hover B.M., Brady S.F. i wsp.: Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens. Nat. Microbiol. 3, 415–422 (2018)
- Howden B.P., Stineare T.P. i wsp.: Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog. DOI: 10.1371/journal.ppat.1002359. (2011)
- Hu F., Zhu D., Wang F., Wang M.: Current Status and Trends of Antibacterial Resistance in China. Clinical Infectious Diseases, 67, 128–134 (2018)
- Iliya S., Mwangi J., Maathai R., Muriuki M.: Phenotypic analysis and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in Kiambu County, Kenya. J. Infect. Dev. Countr. 14, 597–605 (2020)
- Iyer A., Kumosani T., Azhar E., Barbour E., Harakeh S.: High incidence rate of methicillin-resistant Staphylococcus aureus (MRSA) among healthcare workers in Saudi Arabia. J. Infect. Dev. Countr. 8, 372–378 (2014)
- Jerzy K., Francis H.: Chronic Osteomyelitis – Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges. The Open Orthopaedics Journal, 12, 153–163 (2018)
- Junie L.M., Jeican I.I., Matroş L., Pandrea S.L.: Molecular epidemiology of the community-associated methicillin-resistant Staphylococcus aureus clones: a synthetic review. Clujul Medical, 91, 7–11 (2018)
- Juul J.J., Mullins C.F., Peppard W.J., Huang A.M.: New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin. Ther Clin. Risk. Manag. 12, 225–232 (2016)
- Karyński M., Krzysztoń-Russjan J., Grzesiowski P.: Zmiany w epidemiologii inwazyjnych klonów MRSA w wybranych szpitalach w Polsce. Przegląd Medyczny Uniwersytetu Rzeszowskiego i Narodowego Instytutu Leków w Warszawie, 3, 311–317 (2012)
- Khanal A., Sulochan G.C., GaireA., Khanal A., EstradaR., Ghimir R., Panthee P.: Methicillin-resistant Staphylococcus aureus in Nepal: A systematic review and meta-analysis. Int. J. Infect. Dis. 103, 48–55 (2021)
- Kizerwetter-Świda M., Pławińska-Czarnak J.: Odzwierzęce szczepy Staphylococcus aureus oporne na metycylinę (LA--MRSA) – obecny stan wiedzy. Med. Weter. 73, 92–98 (2017)
- Kobayashi S.D., DeLeo F.R.: Towards a Monoclonal Antibody-Based Therapy for Prevention and Treatment of Staphylococcus aureus Infections. J. Infect. Dis. 219, 848–850 (2019)
- Kot B., Wierzchowska K., Piechota M., Grużewska A.: Antimicrobial Resistance Patterns in Methicillin Resistant Staphylococcus aureus from Patients Hospitalized during 2015-2017 in Hospitals in Poland. Med. Prin. Pract. 29, 61–68 (2020)
- Kourtis A.P., Cardo D. i wsp.: Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections – United States. Morbidity and Mortality Weekly Report, 68, 214–219 (2019)
- Kuziemski A., Frankowska K., Gonia E.: Etiologia zakażeń szpitalnych rejestrowanych w Szpitalu Uniwersyteckim nr 2 w Bydgoszczy w latach 2015-2017. Zakażenia XXI wieku, 5, 241–245 (2018)
- Kwapisz E., Garbacz K., Wierzbowska M., Krause K.: Występowanie metycylinoopornych Staphylococcus aureus u dorosłych pacjentów z objawami infekcji jamy ustnej. Medycyna Doświadczalna i Mikrobiologia, 69, 209–214 (2017)
- Lalikian K., Parsiani R., Won R., Chang E., Turner R.B.: Ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case series. J. Chemotherapy, 30, 124–128 (2017)
- Lawal O.U., Ayobami O., Abouelfetouh A., Mourabit N., Kaba M., Egyir B., Abdulgader S.M., Shittu A.O.: A 6-Year Update on the Diversity of Methicillin-Resistant Staphylococcus aureus Clones in Africa: A Systematic Review. Front. Microbiol. DOI: 10.3389/fmicb.2022.860436 (2022)
- Lee A.S., de Lencastre H., Garau J., Kluytmans J., Malhotra-Kumar S., Peschel A., Harbarth S.: Methicillin-resistant Staphylococcus aureus. Nat. Rev. Dis. Primers. 4, 18033 (2018)
- Leong H.N., Kurup A., Tan M.Y., Kwa A.L.H., Liau K.H., Wilcox M.H.: Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infection and Drug Resistance, 11, 1959–1974 (2018)
- Liao F., Mo Z., Gu W., Xu W., Fu X., Zhang Y.: A comparative genomic analysis between methicillin-resistant Staphylococcus aureus strains of hospital acquired and community infections in Yunnan province of China. BMC Infect. Dis. DOI:10.1186/s12879-020-4866-6 (2020)
- Lindsay J.A.: Genomic variation and evolution of Staphylococcus aureus. Int. J. Med. Microbiol. 300, 98–103 (2010)
- Liu C., Chambers H.F i wsp.: Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 52, e18–e55 (2011a)
- Liu C., Chambers H.F. i wsp.: Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin. Infect. Dis. 52, 285–292 (2011b)
- Loewen K., Schreiber Y., Kirlew M., Bocking N., Kelly L.: Community-associated methicillin-resistant Staphylococcus aureus infection. Can. Fam. Physician, 63, 512–520 (2017)
- Lopaciuk U., Dzierżanowska D:. Gronkowce metycylinooporne: mechanizmy oporności, czynniki zjadliwości oraz metody geno-typowania. Postępy Mikrobiologii, 41, 401–418 (2012)
- Lu Y.J., Sasaki T., Kuwahara-Arai K., Uehara Y., Hiramatsu K.: Development of a new application for comprehensive viability analysis based on microbiome analysis by next generation sequencing: insights into Staphylococcal carriage in human nasal cavities. Appl. Environ. Microb. DOI: 10.1128/AEM.00517-18 (2018)
- Ma X., Chang W., Zhang C., Zhou X., Yu F.: Staphylococcal panton-valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils. PLoS ONE, DOI: 10.1371/journal.pone.0034970 (2012)
- Mądry K.: Nowe antybiotyki. Współczesna Onkologia, 2, 52–57 (2004)
- Mertz D., Frei R., Jaussi B., Tietz A., Stebler C., Flückiger U., Widmer A.F.: Throat Swabs Are Necessary to Reliably Detect Carriers of Staphylococcus aureus. Clin. Infect. Dis. 45, 475–477 (2007)
- Michalska K., Tyski S.: Oksazolidynony – nowa grupa chemioterapeutyków przeciwbakteryjnych. Zakażenia, 1, 24–28 (2006)
- Neely M.N., Youn G., Jones B., Jelliffe R.W., Drusano G.L., Rodvold K.A., Lodise T.P.: Are Vancomycin Trough Concentrations Adequate for Optimal Dosing? Antimicrob. Agents Ch. 58, 309–316 (2014)
- Nelson M.U., Gallagher P.G.: Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Semin. Perinatol. 36, 424–430 (2012)
- Neradova K., Jakubu V., Pomorska K., Zemlickova H.: Methicillin-resistant Staphylococcus aureus in veterinary professionals in 2017 in the Czech Republic. BMC Vet. Res. DOI: 10.1186/s12917-019-2223-z (2020)
- Nyasinga J., Omuse G., Njenga J., Nyerere A., Abdulgader S.: Epidemiology of Staphylococcus aureus infections in Kenya: current state, gaps and opportunities. Open Journal of Medical Microbiology, 10, 204–221 (2022)
- Ochiai T.: Staphylococcus aureus Produces Autolysin-Susceptible Cell Walls during Growth in a High-NaCl and Low-Ca2+ Concentration Medium. Microbiol. Immunol. 44, 705–709 (1999)
- Okomo U., Akpalu E.N.K., Doare K.D., Roca A., Cousens S., Jarde A., Sharland M., Kampmann B., Lawn J.E.: Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta--analysis in line with the STROBE-NI reporting guidelines. The Lancet Infectious Diseases, 19, 1219–1234 (2019)
- Panchal V.V., Griffiths C., Mosaei H., Bilyk B., Sutton J.A.F., Carnell O.T., Hornby D.P., Green J., Hobbs J.K., Kelley W.L., Zenkin N., Foster S.J.: Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression. PLOS Pathog. DOI:10.1371/journal.ppat.1008672 (2020)
- Piechota M., Kot B., Frankowska-Maciejewska A., Grużewska A., Woźniak-Kosek A.: Biofilm Formation by Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Strains from Hospitalized Patients in Poland. Biomed. Rese. Int. DOI:10.1155/2018/4657396 (2018)
- Polgreen P.M., Herwaldt L.A.: Staphylococcus aureus colonization and nosocomial infections: implications for prevention. Curr. Infect. Dis. Rep. 6, 435–441 (2004)
- Pomorska-Wesołowska M., Różańska A., Natkaniec J., Gryglewska B., Szczypta A., Dzikowska M., Chmielarczyk A., Wójkowska--Mach J.: Longevity and gender as the risk factors of methicillin-resistant Staphylococcus aureus infections in southern Poland. BMC Geriatr DOI: 10.1186/s12877-017-0442-3 (2017)
- Price M.F., Carlini M., Houston S., Gentry L.O.: Prevalence of nasal colonization with methicillin-resistant Staphylococcus aureus in selected patient populations. Infect. Control. Hosp. Epidemiol. 21, 603–605 (2000)
- Rodvold K.A., McConeghy K.W.: Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future. Clin. Infect. Dis. 58, S20–S27 (2014)
- Sadowy E.: Mobile genetic elements beyond the VanB-resistance dissemination among hospital-associated enterococci and other Gram-positive bacteria. Plasmid, DOI: 10.1016/j.plasmid.2021.102558 (2021)
- Safdar N., Bradley E.A.: The risk of infection after nasal colonization with Staphylococcus aureus. Am. J. Med. 121, 310–315 (2008)
- Schlievert P.M., Strandberg K.L., Lin Y.C., Peterson M.L., Leung D.Y.: Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J. Allergy. Clin. Immunol. 125, 39–49 (2010)
- Schmitz F.J., Jones M.E.: Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? Int. J. Antimicrob. Agents, 9, 1–19 (1997)
- Schwendener S., Cotting K., Perreten V.: Novel methicillin resistance gene mecD in clinical Macrococcus caseolyticus strains from bovine and canine sources. Scientific Reports, DOI: 10.1038/srep43797 (2017)
- Sharma M., Anjum M.F. i wsp.: Livestock-Associated Methicillin Resistant Staphylococcus aureus (LA-MRSA) Clonal Complex (CC) 398 Isolated from UK Animals belong to European Lineages. Front. Microbiol. DOI:10.3389/fmicb.2016.01741 (2016)
- Shaw E., Pujol M. i wsp.: Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial. BMJ Open, DOI:10.1136/bmjopen-2014-006723 (2015)
- Shaw K.J., Barbachyn M.R.: The oxazolidinones: past, present, and future. Ann. N.Y. Acad. Sci. 1241, 48–70 (2011)
- Shi B., Leung D.Y.M., Taylor P.A., Li H.: Methicillin-Resistant Staphylococcus aureus Colonization Is Associated with Decreased Skin Commensal Bacteria in Atopic Dermatitis. J. Invect. Dermatol. 138, 1668–1671 (2018)
- Silva V., Poeta P. i wsp.: Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis. Int. J. Antimicrob. Ag. DOI: 10.1016/j.ijantimicag.2020.106021 (2020)
- Sit P.S., Teh C.S.J., Idri N., Sam I.C., Omar S.F.S., Sulaiman H., Thong K.L., Kamarulzaman A., Ponnampalavanar S.: Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. BMC Infect. Dis. DOI: 10.1186/s12879-017-2384-y (2017)
- Solberg C.O.: Spread of Staphylococcus aureus in hospitals: causes and prevention. Scand. J. Infect. Dis. 32, 587–595 (2000)
- Song K.H., Kim H.B. i wsp.: Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009–2011: a multi-center cohort study. BMC Infect. Dis. 13, 581–589 (2013)
- Tabaja H., Hindy J.R., Kanj S.S.: Epidemiology of Methicillin-Resistant Staphylococcus aureus in Arab Countries of the Middle East and North African (MENA) Region. Mediterranean Journal of Hematology and Infectious Diseases. 13, e2021050 (2021)
- Thomer L., Schneewind O., Missiakas D.: Pathogenesis of Staphylococcus aureus Bloodstream Infections, Annu. Rev. Pathol--Mech. 11, 343–364 (2016)
- Tirupathi R., Areti S., Salim S.A., Palabindala V., Jonnalagadda N.: Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium. Journal of community hospital internal medicine perspectives, 9, 310–313 (2019)
- Totté J.E.E,. van der Feltz W.T, Hennekam M., van Belkum A., van Zuuren E.J.,. Pasmans S.G.M.A : Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis, Brit. J. Dermatol. 175, 687–695 (2016)
- Truszczyński M., Pejsak Z.: Źródła i drogi szerzenia się antybiotykooporności bakterii. Med. Weter. 96, 203–207 (2013)
- Turner N.A., Sharma-Kuinkel B.K., Maskarinec S.A., Eichenberger E.M., Shah P.P., Carugati M., Holland T.L., Fowler Jr V.G.: Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat. Rev. Microbiol. 17, 203–218 (2019)
- Van Alen S., Kaspar U., Idelevich E.A., Köck R., Becker K.: Increase of zinc resistance in German human derived livestock-associated MRSA between 2000 and 2014. Vet. Microbiol. 214, 7–12 (2018)
- Van Cleef A.G.L., Kluytmans A.J.W.: Livestockassiociated Methicillin-Resistant Staphylococcus aureus in Humans, Europe. Emerg. Infect. Dis., 17, 502–505 (2011)
- Van Hal S.J., Jensen S.O., Vaska V.L., Espedido B.A., Paterson D.L., Gosbell I.B.: Predictors of Mortality in Staphylococcus aureus Bacteremia. Clinical Microbiology Reviews, 25, 362–386 (2012)
- Villegas-Estrada A., Lee M., Hesek D., Vakulenko S.B., Mobasheryet S.: Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP2a by two anti-MRSA β-lactam antibiotics. J. Am. Chem. Soc. 130, 9212–9213 (2008)
- Weems J.J., Beck L.B.: Nasal carriage of Staphylococcus aureus as a risk factor for skin and soft tissue infections. Curr Infect. Dis. Rep. 4, 420–425 (2002)
- Wilke M.H., Becker K., Kloss S., Heimann S.M., Goldmann A., Weber B., Pletz M.W., Simon P., Petrik C.: Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin – a retrospective analysis of medical charts and re-imbursement data of real-life patient populations. GMS Infectious Diseases, DOI: 10.3205/id000028 (2017)
- World Health Organization: Antimicrobial resistance surveillance in Europe 2020, 26.01.2022,https://www.ecdc.europa.eu/en/news-events/who-and-ecdc-report-antimicrobial-resistance-remains-health-threat-europe (05.07.2022)
- Yoon Y.K., Kim M.J. i wsp.: Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 58, 317–324 (2014)
- Zasowski E.J., Trinh T.D., Claeys K.C., Casapao A.M., Sabagha N., Lagnf A.M., Klinker K.P., Davis S.L., Rybak M.J.: Multicenter Observational Study of CeftarolineFosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrob. Agents Ch. DOI: 10.1128/AAC.02015-16 (2017)
- Zervou F.N., Zacharioudakis I.M., Ziakas P.D., Mylonakis E.: MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 133, e1015–1023 (2014)
- Zhang F., Wang B., Liu S., Chen Y., Lin Y., Liu Z., Zhang X., Bin Yu B.: Bacillus subtilis revives conventional antibiotics against Staphylococcus aureus osteomyelitis. Microb. Cell Fact. DOI: 10.1186/s12934-021-01592-5 (2021)
- Zigmond J., Pecan L., Hájek P., Raghubir N., Omrani A.: MRSA infection and colonization rates in Africa and Middle East: a systematic review & meta-analysis. International Congress on Infectious Diseases, 21, 391 (2014)
- Ziółkowski G., Pawłowska I., Jachowicz E., Stasiowski M.: Antibiotic Stewardship in Staphylococcus aureus Bloodstream Infection Treatment-Analysis Based on 29,747 Patients from One Hospital. Antibiotics, DOI:10.3390/antibiotics9060338 (2020)
- Mikkaichi T., Yeaman MR., Hoffmann A.: MRSA Systems Immunobiology Group. Identifying determinants of persistent MRSA bacteremia using mathematical modeling. PLoS Comput Biol. 15(7): e1007087. doi:10.1371/journal.pcbi.1007087 (2019)